First Word Pharma reported that UB spinout company POP Biotechnologies, co-founded by Jonathan Lovell, has received $9.7 million to continue development of its nanoparticle vaccine platform.
Environment and Energy Leader featured a column by Maria Lehman on the business case for resilient infrastructure as long-term investments for changing environments.
Technology.org featured research by Vasili Perebeinos and colleagues from Rice University on using films of carbon nanotubes to convert the color of light at greater magnitudes than conventional materials.
